ESPR - Esperion Therapeutics Inc Earnings

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: AMRN LXRX NAMS VKTX IRWD

| Held by: VTI IWM XPH VXF IWN VTWO IWO VHT IWC PRFZ

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.10	Insider Own	4.23%	Shs Outstand	257.40M	Perf Week	-0.95%
Market Cap	803.19M	Forward P/E	11.48	EPS next Y	0.27	Insider Trans	-0.92%	Shs Float	246.54M	Perf Month	52.20%
Enterprise Value	1.19B	PEG	-	EPS next Q	-0.00	Inst Own	69.02%	Short Float	14.77%	Perf Quarter	-9.83%
Income	-7.42M	P/S	1.92	EPS this Y	63.64%	Inst Trans	23.93%	Short Ratio	3.47	Perf Half Y	8.33%
Sales	418.24M	P/B	-	EPS next Y	779.17%	ROA	-1.89%	Short Interest	36.43M	Perf YTD	-15.68%
Book/sh	-1.20	P/C	5.14	EPS next 5Y	-	ROE	-	52W High	4.18 -25.27%	Perf Year	299.64%
Cash/sh	0.61	P/FCF	-	EPS past 3/5Y	68.58% 53.87%	ROIC	-4.84%	52W Low	0.69 350.54%	Perf 3Y	102.60%
Dividend Est.	-	EV/EBITDA	15.70	Sales past 3/5Y	74.80% 12.12%	Gross Margin	68.38%	Volatility	0.58% 4.38%	Perf 5Y	-86.07%
Dividend TTM	-	EV/Sales	2.85	EPS Y/Y TTM	92.51%	Oper. Margin	18.12%	ATR (14)	0.14	Perf 10Y	-78.79%
Dividend Ex-Date	-	Quick Ratio	1.18	Sales Y/Y TTM	61.13%	Profit Margin	-1.77%	RSI (14)	71.67	Recom	3.14
Dividend Gr. 3/5Y	- -	Current Ratio	1.53	EPS Q/Q	51.43%	SMA20	25.53%	Beta	0.97	Target Price	3.19
Payout	-	Debt/Eq	-	Sales Q/Q	23.25%	SMA50	23.26%	Rel Volume	1.16	Prev Close	3.13
Employees	294	LT Debt/Eq	-	Earnings	May 08 BMO	SMA200	8.86%	Avg Volume	10.51M	Price	3.12
IPO	Jun 26, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	-169.54% -5.23%	Trades		Volume	12,182,963	Change	-0.32%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)